Oragenics, Inc. (OGEN) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
OGEN Revenue Growth
Revenue Breakdown (FY 2023)
OGEN's revenue distribution by segment and geography for fiscal year 2023
By Product/Segment
OGEN Revenue Analysis (2014–2025)
As of May 8, 2026, Oragenics, Inc. (OGEN) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, OGEN's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $1.2 million in 2015.
Revenue diversification analysis shows OGEN's business is primarily driven by Grant (100%). With over half of revenue concentrated in Grant, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including SIGA (-22.1% YoY), ADMA (+11.0% YoY), and NVAX (-52.5% YoY). Compare OGEN vs SIGA →
OGEN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| OGENCurrent | $0 | - | - | - | |
 SIGA | $95M | -22.1% | -5.4% | 25.1% | |
 ADMA | $510M | +11.0% | +64.6% | 37.5% | |
 NVAX | $1.1B | -52.5% | +118.8% | 50.1% | |
 DYAI | $3M | -21.9% | +15.8% | -168.8% | |
 VXRT | $237M | +726.7% | +125.8% | 7.6% |
OGEN Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-9,362,503 | - |
| 2024 | $0 | - | $0 | - | $-10,558,815 | - |
| 2023 | $0 | - | $0 | - | $-20,904,903 | - |
| 2022 | $0 | - | $0 | - | $-14,420,768 | - |
| 2021 | $0 | - | $0 | - | $-15,771,018 | - |
| 2020 | $0 | - | $-22,107,563 | - | $-26,641,456 | - |
| 2019 | $0 | - | $-62,622 | - | $-15,878,000 | - |
| 2018 | $0 | - | $-30,110 | - | $-9,994,000 | - |
| 2017 | $0 | - | $-65,803 | - | $-6,718,318 | - |
| 2016 | $0 | -100.0% | $-75,044 | - | $-8,542,505 | - |
See OGEN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OGEN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OGEN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOGEN — Frequently Asked Questions
Quick answers to the most common questions about buying OGEN stock.
Is OGEN's revenue growth accelerating or slowing?
OGEN TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is OGEN's long-term revenue growth rate?
Oragenics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is OGEN's revenue distributed by segment?
OGEN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.